Comprehensive Urology Studies ED Injections with Shockwave Therapy for Penile Girth Enhancement
23 sept. 2024 15h34 HE
|
Comprehensive Urology
Comprehensive Urology of Los Angeles studies STUD Protocol for male enhancement in survivors of prostate cancer during Prostate Cancer Awareness Month.
Curium: Erste Kommerzielle Dosen von PYLCLARI® in Deutschland Verfügbar - Ein Innovativer 18f-PSMA PET Tracer für Patienten Mit Prostatakrebs
06 mai 2024 04h25 HE
|
Curium
PARIS, May 06, 2024 (GLOBE NEWSWIRE) -- Curium, ein weltweit führendes Unternehmen der Nuklearmedizin, gab heute bekannt, dass in München und Nürnberg die ersten kommerziellen Dosen von PYLCLARI®...
Curium Announces First Commercial Doses in Germany of PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer
06 mai 2024 04h25 HE
|
Curium
Curium announced that today in Munich and Nurnberg, Germany the first commercial doses of PYLCLARI® have been delivered.
CURIUM ANNUNCIA LE PRIME DOSI COMMERCIALI IN ITALIA DI PYLCLARI® - UN INNOVATIVO TRACCIANTE PET 18F-PSMA INDICATO NEI PAZIENTI CON TUMORE ALLA PROSTATA
07 mars 2024 08h51 HE
|
Curium
Parigi, Francia, March 07, 2024 (GLOBE NEWSWIRE) -- Curium, leader mondiale nella medicina nucleare, ha annunciato oggi la vendita delle prime dosi commerciali di PYLCLARI® in Italia. PYLCLARI®...
Curium Announces First Commercial Doses in Italy of PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer
07 mars 2024 08h51 HE
|
Curium
PARIS, March 07, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that the first commercial doses of PYLCLARI® have been sold in Italy. PYLCLARI® (INN:...
Curium Announces Submission of the Marketing Authorization Application for PYLCLARI®, an Innovative (18F)-PSMA PET Tracer Indicated in Adults With Prostate Cancer to Swissmedic
22 févr. 2024 06h19 HE
|
Curium
PARIS, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that the marketing authorization application for PYLCLARI® (INN: Piflufolastat (18F) formerly...
US Urologists Industry Report 2023: Five-Year Forecasts and Key Player Analysis
01 nov. 2023 09h13 HE
|
Research and Markets
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Urologists in the US - Industry Market Research Report" has been added to ResearchAndMarkets.com's offering. This report offers valuable insights...
Urinary Tract Infection Testing Market to hit USD 1 billion by 2032, says Global Market Insights Inc.
29 oct. 2023 09h51 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 29, 2023 (GLOBE NEWSWIRE) -- Urinary Tract Infection Testing Market size is expected to be worth USD 1 billion by 2032. According to the study, industry increase is driven...
Outlook on the Urinary Tract Infection Testing Global Market to 2030 - Featuring Accelerate Diagnostics, Bio-Rad Laboratories and Danaher Among Others
30 août 2022 08h33 HE
|
Research and Markets
Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The "Global Urinary Tract Infection Testing Market Size, Share & Trends Analysis by Type (Urethritis, Cystitis, Pyelonephritis), by End-Use (Reference...
Kidney Stones: Very Scary True Stories. And Entombed Mysteries.
02 oct. 2015 12h17 HE
|
ARUP Laboratories
SALT LAKE CITY, Oct. 2, 2015 (GLOBE NEWSWIRE) -- It woke me up in the middle of the night.
It left me gasping and sobbing. Screaming.
Someone was sticking a knife in me and slowly turning...